Abstract:Cancer-associated fibroblasts (CAFs), the most abundant stromal components in the tumor microenvironment of esophageal cancer, secrete chemokines that play important roles in tumor cell survival and proliferation, angiogenesis, immune evasion and metastasis. Through the specificity of molecular imaging, the expression of these chemokines and their receptors can be noninvasively visualized, thereby providing valuable insights for the diagnosis of esophageal cancer. Given the pivotal roles of these chemokines in various malignant biological behaviors of tumors, targeting their upstream and downstream signaling pathways with specific antagonists or antibodies holds promise for remodeling the tumor immune microenvironment, modulating immune responses, and inhibiting the growth and metastasis of esophageal cancer. Moreover, the expression levels of these chemokines are closely associated with patient prognosis, and their dynamic monitoring may enable accurate prediction of clinical outcomes. In this review, we summarize the roles and recent advances in research on chemokines derived from CAFs in esophageal cancer, aiming to provide new insights into its diagnosis, treatment, and prognosis.